Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,246.00
Ask: 12,248.00
Change: 56.00 (0.46%)
Spread: 2.00 (0.016%)
Open: 12,304.00
High: 12,356.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Tue, 04th Nov 2014 06:13

UK Earnings, Trading Statements Calendar
Tuesday, November 4 
Advanced Computer Software GroupHalf Year Results
Associated British FoodsFull Year Results
Legal & General GroupInterim Management Statement
GlencoreInterim Management Statement
Weir GroupInterim Management Statement
Hilton Food GroupInterim Management Statement
Imperial Tobacco GroupFull Year Results
Jardine Lloyd Thompson GroupInterim Management Statement
PersimmonInterim Management Statement
Unite GroupInterim Management Statement
OneSavings BankInterim Management Statement
888 HoldingsTrading Update
Wednesday, November 5 
Lancashire HoldingsQ3 Results
First DerivativesHalf Year Results
Avocet MiningInterim Management Statement
MeggittInterim Management Statement
Marks & Spencer GroupHalf Year Results
FirstGroupHalf Year Results
Mithras Investment TrustInterim Management Statement
Old MutualInterim Management Statement
JD WetherspoonInterim Management Statement
WincantonInterim Management Statement
HuntingHalf Year Results
MarshallsInterim Management Statement
Drax GroupInterim Management Statement
esure GroupInterim Management Statement
AlentInterim Management Statement
Thursday, November 6 
Promethean WorldInterim Management Statement
Tate & LyleHalf Year Results
Shanks GroupHalf Year Results
Dairy CrestHalf Year Results
Coca-Cola HBC AGQ3 Results
AstraZenecaQ3 Results
STV GroupInterim Management Statement
Croda InternationalInterim Management Statement
DS SmithTrading statement
Costain GroupInterim Management Statement
Intu PropertieInterim Management Statement
ExperianHalf Year Results
BeazleyInterim Management Statement
Cable & Wireless CommunicationsHalf Year Results
Halfords GroupHalf Year Results
InmarsatQ3 Results
London MiningInterim Management Statement
Randgold ResourcesQ3 Results
RightmoveInterim Management Statement
RSA Insurance GroupInterim Management Statement
SchrodersInterim Management Statement
SynthomerInterim Management Statement
WM Morrison SupermarketsInterim Management Statement
Hikma PharmaceuticalsInterim Management Statement
CobhamInterim Management Statement
Stock Spirits GroupInterim Management Statement
SuperGroupTrading statement
Friday, November 7 
Croda InternationalInterim Management Statement
Scottish Mortgage Investment TrustHalf Year Results
Spirax-Sarco EngineeringHalf Year Results
Ark Therapeutics GroupInterim Management Statement
Capital & RegionalInterim Management Statement
Rentokil InitialTrading statement
Admiral GroupInterim Management Statement
National GridHalf Year Results
Capital & Counties PropertiesInterim Management Statement
Bovis Homes GroupInterim Management Statement
Monday, November 10 
BATM Advanced CommunicationsInterim Management Statement
e2v technologiesHalf Year Results
Carrs Milling IndustriesFull Year Results
HammersonInterim Management Statement
LonminFull Year Results
Morgan Advanced MaterialsInterim Management Statement
Pacific HorizonInterim Management Statement
RedrowInterim Management Statement
Industrial Multi Property TrustInterim Management Statement
Aveva GroupHalf Year Results
Just RetirementInterim Management Statement
Macau Property Opportunities FundInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.